DaVita (NYSE:DVA) Shares Gap Up to $88.26

DaVita Inc. (NYSE:DVAGet Rating)’s stock price gapped up before the market opened on Thursday . The stock had previously closed at $88.26, but opened at $90.77. DaVita shares last traded at $90.42, with a volume of 69 shares trading hands.

Analyst Upgrades and Downgrades

A number of research firms recently commented on DVA. Deutsche Bank Aktiengesellschaft decreased their target price on shares of DaVita from $150.00 to $97.00 and set a “buy” rating for the company in a research report on Tuesday, August 2nd. UBS Group raised their price target on shares of DaVita from $106.00 to $117.00 and gave the stock a “buy” rating in a report on Friday, August 19th. Truist Financial decreased their price target on shares of DaVita from $110.00 to $90.00 and set a “hold” rating for the company in a report on Wednesday, June 22nd. Cowen decreased their price target on shares of DaVita to $95.00 in a report on Tuesday, August 9th. Finally, Bank of America decreased their price target on shares of DaVita from $110.00 to $90.00 and set an “underperform” rating for the company in a report on Tuesday, June 21st. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, DaVita has a consensus rating of “Hold” and a consensus target price of $100.43.

DaVita Price Performance

The stock has a market cap of $8.46 billion, a price-to-earnings ratio of 11.49, a price-to-earnings-growth ratio of 1.42 and a beta of 1.14. The stock’s 50 day moving average price is $87.40 and its two-hundred day moving average price is $98.47. The company has a quick ratio of 1.37, a current ratio of 1.41 and a debt-to-equity ratio of 11.69.

DaVita (NYSE:DVAGet Rating) last released its quarterly earnings data on Monday, August 1st. The company reported $2.30 earnings per share for the quarter, topping analysts’ consensus estimates of $2.09 by $0.21. The firm had revenue of $2.93 billion for the quarter, compared to analyst estimates of $2.93 billion. DaVita had a net margin of 7.17% and a return on equity of 84.69%. The business’s quarterly revenue was up .4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.64 earnings per share. Equities research analysts forecast that DaVita Inc. will post 7.64 EPS for the current fiscal year.

Insider Activity at DaVita

In other news, COO Michael David Staffieri purchased 20,000 shares of the company’s stock in a transaction that occurred on Thursday, June 23rd. The shares were bought at an average price of $77.70 per share, for a total transaction of $1,554,000.00. Following the completion of the transaction, the chief operating officer now owns 61,190 shares in the company, valued at $4,754,463. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.00% of the stock is owned by company insiders.

Institutional Trading of DaVita

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Elo Mutual Pension Insurance Co acquired a new stake in shares of DaVita in the first quarter valued at about $1,162,000. Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in shares of DaVita in the first quarter valued at about $206,000. FORA Capital LLC acquired a new stake in shares of DaVita in the first quarter valued at about $251,000. FourThought Financial LLC grew its position in shares of DaVita by 49.6% in the first quarter. FourThought Financial LLC now owns 510 shares of the company’s stock valued at $56,000 after purchasing an additional 169 shares during the period. Finally, Natixis Advisors L.P. grew its position in shares of DaVita by 9.3% in the first quarter. Natixis Advisors L.P. now owns 85,476 shares of the company’s stock valued at $9,668,000 after purchasing an additional 7,266 shares during the period. Institutional investors and hedge funds own 88.47% of the company’s stock.

About DaVita

(Get Rating)

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Further Reading

Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.